Omada Health, Inc. Common Stock OMDA
Analyst Ratings
- Consensus
- Buy — 11 Buy · 2 Hold · 0 Sell (13 analysts)
- Avg. Price Target
- $26.85 (+31.0% upside)
Key Stats
- Today's Range
- $19.94 – $21.09
- 50-Day Range
- $18.24 – $25.45
- 52-Week Range
- $10.28 – $26.91
- Volume
- 997K shs
- Average Volume
- 1.37 million shs
- Market Cap
- $1.20 billion
- P/E Ratio
- 89.13
- Dividend Yield
- —
Valuation
- P/E Ratio
- 89.13
- Price / Book
- 4.76
- Price / Sales
- 3.89
Short Interest
- Short Interest
- 1.88%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $309.76 million
- Net Income
- $4.30 million
- Net Margin
- 1.39%
- Return on Equity
- 1.70%
- Debt-to-Equity
- —
About Omada Health, Inc. Common Stock
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.
Related Stocks
Compare head-to-head: OMDA vs LFST·OMDA vs PRVA·OMDA vs USPH
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
